ArticleThe Journal of clinical investigation2026

Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancer.

Rashmi Mishra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.